Thomas Brian C. sold Metagenomi, Inc. ($MGX) shares on the open market three times over the last year, for a total of about $30,549. His most recent insider sale occurred on December 5, 2025. These MGX insider sales rank 10,802nd out of 11,678 individual insiders, well below the average of $8.6 million per person and 6.4 transactions. Thomas Brian C. recorded no open market purchases of MGX shares.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec. 5, 2025 | Metagenomi Therapeutics, Inc. | $MGX | Thomas Brian C. | Not found | S | Common Stock | 3830 | $1.77 | 2,510,960.0000 | 37,546,751 | 0.15% | 0.01% |
| Sept. 5, 2025 | Metagenomi Therapeutics, Inc. | $MGX | Thomas Brian C. | Not found | S | Common Stock | 2701 | $1.81 | 2,514,790.0000 | 1,870,923 | 0.11% | 0.14% |
| June 6, 2025 | Metagenomi Therapeutics, Inc. | $MGX | Thomas Brian C. | Chief Executive Officer | S | Common Stock | 10785 | $1.75 | 2,517,491.0000 | 1,870,923 | 0.43% | 0.58% |
| April 1, 2025 | Metagenomi Therapeutics, Inc. | $MGX | Thomas Brian C. | Chief Executive Officer | A | Stock Option (Right to Buy) | 196000 | $0.00 | 196,000.0000 | 1,870,923 | 9999.99% | 10.48% |
| April 1, 2025 | Metagenomi Therapeutics, Inc. | $MGX | Thomas Brian C. | Chief Executive Officer | A | Common Stock | 32000 | $0.00 | 2,528,276.0000 | 1,870,923 | 1.28% | 1.71% |
| April 1, 2024 | Metagenomi Therapeutics, Inc. | $MGX | Thomas Brian C. | Chief Executive Officer | A | Common Stock | 118992 | $0.00 | 2,496,276.0000 | 3,884,740 | 5.01% | 3.06% |
| April 1, 2024 | Metagenomi Therapeutics, Inc. | $MGX | Thomas Brian C. | Chief Executive Officer | A | Stock Option (Right to Buy) | 500323 | $0.00 | 500,323.0000 | 3,884,740 | 9999.99% | 12.88% |